CD4 and neoplasm: Moreover, tumor-infiltrating CD4 and CD8 T cells were decreased in the GSK591-treated group, whereas infiltrating NK, B, macrophages, and Treg cells were not significantly different between the two groups (Supplementary Figures 3A-E).